Evidence map›Paper›PMID 28273966›Full record

ArticleJournal of clinical and diagnostic research : JCDR2017

Charu Nayyar, Preeti Thakur, Vibhor Tak, Karnika Saigal

Abstract read
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Insights into antibiotic resistance and prevalence ofNew microbes and new infections · 2025
    Review
  6. Article
  7. Multicenter epidemiology ofFrontiers in microbiology · 2025
    Article
  8. Article
  9. Article
  10. Frontiers in oncology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Prevalence and Antibiotic Resistance ofHealth services research and managerial epidemiology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Charu NayyarSenior Resident, Department of Clinical Microbiology and Infectious Diseases, Chacha Nehru Bal Chikitsalaya , Delhi, India .
Preeti ThakurSenior Resident, Department of Clinical Microbiology and Infectious Diseases, Chacha Nehru Bal Chikitsalaya , Delhi, India .
Vibhor TakAssistant Professor, Department of Clinical Microbiology and Infectious Diseases, Chacha Nehru Bal Chikitsalaya , Delhi, India .
Karnika SaigalAssistant Professor, Department of Clinical Microbiology and Infectious Diseases, Chacha Nehru Bal Chikitsalaya , Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

aimTo determine the prevalence of infection, antimicrobial susceptibility pattern and clinical outcome of MATERIALS AND

methodsThis was a retrospective study conducted over a period of eight months, i.e., October 2015 to May 2016. All clinical samples received in the microbiology laboratory during the study period were processed using standard microbiological procedures.

resultsA total of 16,234 clinical specimens were received in the microbiology laboratory in the study period, with 2,734 pathogenic bacteria isolated. A total of 1,339 (1.7% of total isolates) Gram-negative bacteria were isolated, out of which 414 were non-fermenters. Among the non-fermenters, 23 (5.5%) were

conclusion

Indexed as

Gram-negativeLevofloxacinTrimethoprim-sulphamethoxazole

Identifiers

PMID28273966
PMCPMC5324411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.